Common Contracts
3 similar Consulting Agreement contracts by Tcr2 Therapeutics Inc.
EX-10.11 16 d555750dex1011.htm EX-10.11 TCR2 THERAPEUTICS INC. AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • May 5th, 2020 • Massachusetts
This Amended and Restated Consulting Agreement (the “Agreement”), made this 9th day of May, 2017 (“Effective Date”), is entered into by TCR2 Therapeutics Inc., a Delaware corporation (the “Company”), Mitchell Finer (the “Dr. Finer”), and Pattern Recognition Ventures (the “Consultant” and, collectively with the Company and Dr. Finer, the “Parties”).
TCR2 THERAPEUTICS INC. AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • December 28th, 2018 • Tcr2 Therapeutics Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Consulting Agreement (the “Agreement”), made this 9th day of May, 2017 (“Effective Date”), is entered into by TCR2 Therapeutics Inc., a Delaware corporation (the “Company”), Mitchell Finer (the “Dr. Finer”), and Pattern Recognition Ventures (the “Consultant” and, collectively with the Company and Dr. Finer, the “Parties”).
TCR2 THERAPEUTICS INC. AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • September 7th, 2018 • Tcr2 Therapeutics Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Consulting Agreement (the “Agreement”), made this 9th day of May, 2017 (“Effective Date”), is entered into by TCR2 Therapeutics Inc., a Delaware corporation (the “Company”), Mitchell Finer (the “Dr. Finer”), and Pattern Recognition Ventures (the “Consultant” and, collectively with the Company and Dr. Finer, the “Parties”).
